New UK Pathway To Cut Access Times For Breakthrough Products By Up To Four Years

The government’s much heralded response to the UK’s Accelerated Access Review backs proposals such as an accelerated pathway for “transformative” new products, improved horizon scanning, and more flexible commercial arrangements. Former GSK CEO Sir Andrew Witty will chair a new group responsible for selecting products for the new pathway.